Pharma & Biotech
The existing security holders of Albert Labs will receive 38.6 million post-consolidation shares of the...
Valeo Pharma making progress as it bids to become leading Canada-focused specialty pharma group
Numinus Wellness looking to position itself at the forefront of psychedelics for healing and wellness
Zynerba in exciting run-up to clinical readouts on CBD skin gel Zygel to treat Fragile X syndrome
Only registered members can use this feature.
Copyright © Proactive 2021.
All Rights Reserved - Proactive North America Inc., Proactive Investors LLC.